Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 92 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 7563883

    Recombinant P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  2. US 7563596

    Method of modulating tissue growth using Frzb protein

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  3. US 7560118

    Attenuated dengue virus comprising mutations in the NS3 gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  4. US 7557196

    hGC-1, a gene encoding a member of the olfactomedin-related protein family

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  5. US 7553490

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  6. US 7547762

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  7. US 7547773

    Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  8. US 7544789

    DNA encoding Toxoplasma gondii rDGP5p protein

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  9. US 7541034

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  10. US 7541040

    Chimeric molecule for the treatment of th2-like cytokine mediated disorders

    The United States of America as represented by the Department of Health and Human Serivces · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  11. US 7541139

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  12. US 7541043

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  13. US 7541035

    Immunogenic peptides for the treatment of prostate and breast cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  14. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted May 26, 2009 · Expires May 21, 2029

    granted

  15. US 7534565

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted May 19, 2009 · Expires May 14, 2029

    granted

  16. US 7531352

    Inducible plasmid vector encoding TGF-β and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 12, 2009 · Expires May 7, 2029

    granted

  17. US 7531635

    MATER-protein specific antibodies and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 12, 2009 · Expires May 7, 2029

    granted

  18. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  19. US 7527797

    Vibrio cholerae 0139 conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  20. US 7527802

    Vaccine for transcutaneous immunization

    The United States of America as represented by the Secretary of the Army · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  21. US 7524508

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  22. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  23. US 7521063

    Multiple CPG oligodeoxynucleotides and their use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  24. US 7521479

    Methods of treating prion disease in mammals

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.